What is Alkermes's current debt?

Alkermes (ALKS) reported current debt of $26.5M in Q1 2026.

What is the long-term trend for Alkermes's current debt?

Over 4 years (2020 to 2025), Alkermes's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $2.84M to $0.

Alkermes ALKS Current Debt

Current Debt at other companies

Bristol-Myers SquibbBMY

$2.31B-35.1%

Jazz PharmaceuticalsJAZZ

$1.03B+3,224%

AbbVieABBV

$0-100%

Axsome TherapeuticsAXSM

$70M—

Royalty PharmaRPRX

$380M-61.9%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's current debt?: Alkermes (ALKS) reported current debt of $26.5M in Q1 2026.
What is the long-term trend for Alkermes's current debt?: Over 4 years (2020 to 2025), Alkermes's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $2.84M to $0.